Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Beta Drugs Ltd.
Swot
Beta Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Beta Drugs Ltd. has 10 Strengths, 8 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(8)
Opportunity
(1)
Threats
(0)
Others
(2)
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Week
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Low Piotroski Score : Companies with weak financials
Companies Increasing Debt as per Annual Report
Stocks Underperforming their Industry Price Change in the Quarter
FII / FPI or Institutions increasing their shareholding
Bullish or Bearish Candlestick Strength - Indices
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
